This is a retrospective study of 15 cases with symptomatic basilar artery atherosclerotic chronic stenosis. One patient presented with reversible ischemic neurological deficits and another with completed infarction, the rest of patients presented with progressive transient neurological deficits (TIA) that was refractory to medical treatment. The protocol of PTA included the use of single lumen balloon catheter (Stealth; Boston Scientific, Boston, MT) and the pre-balloon inflation injection of Urokinase (UK). All lesions were successfully dilated except for one. Those with uncomplicated successful dilatation had good control of their neurological status with disappearance of the pre-PTA TIA. The authors conclude that PTA for basilar artery atherosclerotic lesions is possible and a promising procedure when the patients are carefully selected and the operation is performed by a team with good experience in such lesions.
Introduction
The utilization of percutaneous transluminal angioplasty (PTA) for the dilatation of stenotic arteries included the coronary, peripheral, subclavian, and extracranial cerebral arteries. From the intracranial cerebral vessels attention was mainly toward the middle cerebral artery. Recently interest was also toward applying the same concept for lesions involving other intracranial arteries including the basilar artery (BA). The limitation for applying PTA for basilar artery stenotic lesion is primarily due to the fear of damaging the important basilar artery perforators to the brain stem and the thalamichypothalamic regions. Progression in intravascular surgery from improving micro catheters, balloon, as well as real time angiography resulted in more application of PTA to lesions of the basilar artery.
Methods
Radiological imaging includes CT scan, MRI, 3D-CT angiography, MRA, SPECT, and conventional cerebral angiography are performed. Patients subjected to BA-PTA are those with symptoms refractory to medical treatment, or patient in stroke-in-evolution, showing significant stenosis defined as 70% or more. We consider PTA to be risky and do not perform it in the following situations: 1) Arterial dissection can not be ruled out, 2) Long segment of stenosis, 3) acute or the subacute stage, and 4) Eccentric stenotic lesion (relative contraindication). By a coaxial method a 6 French guiding catheter preferably positioned in the left vertebral artery at C2 level and a heparinized saline flushing system is connected. A single lumen angioplasty balloon microcatheter (BC); (Stealth; Boston scientific, Boston, MT) is used. The maximum size of the diameter of the BC should match, or be less than, the diameter of the artery segments immediately above and below the stenotic portion, and never exceeding it. We usually prefer to use the 10 mm BC length. After positioning across the stenosis half concentration contrast through 1 cc syringe is injected into the BC and the indentation of the balloon caused by the stenosis is observed. A bolus of urokinase is typically injected before the first and every subsequent balloon inflation. Balloon inflation then proceeds in a gradual increasing technique in both the maximum pressure and the time duration of the inflation.
In order to decrease the risk of the arterial rupture the aim of the procedure should never be to reach 100% dilatation. Post-PTA final angiography is performed. The procedure is defined as successful if the stenosis is reduced to less than 50% of the pre-PTA stenosis. Clinical success is achieved if the procedure was completed with no complication related directly to the PTA and post dilatation the patient continue to have no more or decrease in the presenting symptoms. Heparin infusion is continued for 24 hours after the PTA, the dose of which is guarded by the level of ACT aiming at twice times the basal-level. The patient is also started on argatroban for seven days. Aspirin in a dose of 80 mg is continued for at least 6 months after the procedure.
Results
Fifteen patients, 13 males and 2 females, with clinical and hemodynamic significant stenosis defined as 70% or more involving the basilar artery were managed by percutaneous transluminal angioplasty (PTA). All cases had a focal stenosis that is of a short length. Eleven patients had other associated vascular pathologies at the time of management of the basilar artery stenosis. Thirteen patients presented with TIA. One patient had reversible ischemic neurological deficits, and one patient presented with mild completed stroke. Six patients had old infarction in the distribution of the basilar artery branches displayed on the MRI. All lesions were called angiographic successful dilation except for one ( figure 1) .
The later had TIA during passing the microguide wire across the stenotic segment and the procedure had to be terminated. Those with uncomplicated successful dilatation had good control of their neurological status with disap-pearance of the pre-PTA presenting symptoms. Complications occurred in two patients, both had subarachnoid hemorrhage secondary to vessel dissection. In one of these patients had the onset of sudden headache and repeated vomiting on the transfer to the ICV. Emergency CT scan showed SAH. Apart form requiring ventriculo-peritoneal shunt and a residual third cranial nerve palsy, the patient recovered completely. The other patient had the onset of intracranial bleeding intra operative requiring craniotomy for evacuation, later he died. Both of the dissection cases was fully dilated from 85% and 90% stenosis respectivly, although this was not the persisting aim. Cerebral angiography, MRA, and 3D CT angiography were obtained in the follow-up period. Of the 12 uncomplicated PTA patients 11 remained clinically asymptomatic till the last follow-up visit. The immediate angiography following PTA showed full dilatation in only three patients, the remaining 11 patients had residual stenosis ranging between 5% to 30%. Two patients showed angiographic significant restenosis that is 50% or more, one of them was clinically free of any symptoms and SPECT showed maintained cerebral blood flow while the other started to have recurrence ofTIA. The later underwent a second PTA procedure which decreased the stenosis from 60% to 20% with complete disappearance of the TIA. It is worth noting that SPECT was not so useful in detecting and following posterior fossa ischemic lesions.
Discussion
Up to 50% of patients with vertebrobasilar occlusion will progress to brain death 1 with up to 86 % mortality rate 2. Since its introduction in 1964 the technique of percutaneous transluminal angioplasty (PTA) underwent tremendous changes and development 3 . However, its application for intracranial cerebrovascular stenosis is still a controversy, especially in the posterior circulation. Several reports in the literature (mainly case reports) have addressed PTA for basilar artery stenosis as more difficult to treat than other intracranial vessels and carry a more significant risk 4. The treatment should only be offered to patients who did not benefit from a full medical support 5. Selection criteria includes: 1) Persis-Interventional Neuroradiology 6 (Suppl1): [155] [156] [157] [158] 2000 tence of symptoms with applied extensive medical therapy, 2) Patient is not in the acute stage of infarction, 3) Stenosis of at least 70% associated with clinical picture that correlate will with the basilar territory, 4) Stenosis is only of short length.
Mechanisms of risk involved in PTA for the basilar artery includes: 1) Temporary occlusion of the perforating vessels during balloon inflation resulting in hemodynamic decrease in blood flow, 2) Intimal endothelial ischemic damage from sustained balloon inflation, 3) Intimal injury by the friction effect from passing the microguide wire or balloon catheter across the stenotic segment causing intimal dissection or vessel rupture, 4) Distal embolization 5,6,7. We selected to ovoid treating acute occlusion to avoid the possible risk of hemorrhagic transformation of the infarcted tissue with its grave results in the brain stem 6. The technique that we use involves the slow gradual increase in pressure inflation in each balloon catheter diameter and the gradual increase in the size of the diameter of the balloon catheter form the 2 mm to the 3 mm size. To decrease the risk of complication full dilatation should never be the aim 5. Detecting the post-PTA improvement in the regional cerebral blood flow has been reported to be the main point indicate satisfaction with the result of the PTA even in the presence of residual stenosis 7. Two of the three patients who had full dilation in our cases formed the only complication.
The long-term benefit of PTA over medical therapy in the posterior circulation has been shown previously 7. None of the patients in this series had any evidence neither of embolic events nor of immediate post dilatation thrombosis of the basilar artery.
Conclusions
Percutaneous angioplasty of stenotic lesions of the basilar artery is a promising procedure if properly applied by an experienced intravascular group. The first step to successful procedure is careful patient selection and preparation. All medical methods should be fully used prior to considering PTA. When patients are properly selected and prepared, and the procedure is systematically well applied encouraging results are to be expected with relatively low complications.
